CD4 and influenza: Overall, our findings suggest that heterologous infection or immunization priming of CD4+ T cells can be used to enhance both the early GC response, including the GC Tfh and GC B cell magnitude, and establishment of CD4+ TRM cells that respond to influenza challenge.